CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.75
+0.25 (2.38%)
Jul 6, 2026, 12:43 PM GMT
CRISM Therapeutics Revenue
In the year 2025, CRISM Therapeutics had annual revenue of 231.00K GBP with 824.00% growth.
Revenue
231.00K
Revenue Growth
+824.00%
P/S Ratio
25.24
Revenue / Employee
57.75K
Employees
4
Market Cap
5.83M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 231.00K | 206.00K | 824.00% |
| Dec 31, 2024 | 25.00K | -20.00K | -44.44% |
| Dec 31, 2023 | 45.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 9.76M |
| Futura Medical | 1.70M |
| Fusion Antibodies | 1.60M |
| Oxford BioDynamics | 1.20M |
| OptiBiotix Health | 1.17M |
| Physiomics | 1.01M |
| Genflow Biosciences | 585.61K |
| Thalia Therapeutics | 7.26K |
CRISM Therapeutics News
- 10 months ago - AIM Market Roundup: Renalytix, Sunrise Resources, Crism Therapeutics - The Armchair Trader
- 1 year ago - AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence - The Armchair Trader
- 1 year ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader